Anti-NMDAR encephalitis in Crohn's disease undergoing long-term infliximab treatment: A case report.

Oh, Shin Ju; Kwon, Young Nam; Lee, Chang Kyun; Lee, Jin San

Oh, Shin Ju; Kwon, Young Nam; Lee, Chang Kyun; Lee, Jin San.

Afiliación

Oh SJ; Center for Crohn's and Colitis, Department of Gastroenterology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea.
Kwon YN; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Lee CK; Center for Crohn's and Colitis, Department of Gastroenterology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea.
Lee JS; Department of Neurology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea.

Front Immunol ; 13: 957575, 2022.

Article en En | MEDLINE | ID: mdl-36389693

Asunto(s)

Encefalitis Antirreceptor N-Metil-D-Aspartato; Enfermedad de Crohn; Masculino; Humanos; Recién Nacido; Adulto; Encefalitis Antirreceptor N-Metil-D-Aspartato/diagnóstico; Infliximab/efectos adversos; Enfermedad de Crohn/complicaciones; Enfermedad de Crohn/tratamiento farmacológico; Estudios de Casos y Controles; Inhibidores del Factor de Necrosis Tumoral; Factor de Necrosis Tumoral alfa/uso terapéutico

Palabras clave

Crohn 's disease; anti-N-methyl-D-aspartate; anti-tumor necrosis factor-α; autoimmune encephalitis; infliximab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Encefalitis Antirreceptor N-Metil-D-Aspartato Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans / Male / Newborn Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google